<DOC>
	<DOCNO>NCT00000702</DOCNO>
	<brief_summary>To test whether zidovudine ( AZT ) useful treatment neurologic syndrome call AIDS dementia complex . To determine long AZT take reach cerebral spinal fluid ( CSF ) , long , concentration find . HIV infection result impairment function brain spinal cord , lead disturbance ability think clearly strength coordination . This disorder , call AIDS dementia complex , may due direct effect HIV nervous system . It know AZT get brain extent , may reduce growth HIV . It hop AZT stabilize improve symptom AIDS dementia complex .</brief_summary>
	<brief_title>A Multicenter Placebo-Controlled Double-Blind Trial Evaluate Azidothymidine ( AZT ) Treatment AIDS Dementia Complex Central Nervous System ( CNS ) Human Immunodeficiency Virus ( HIV ) Infection</brief_title>
	<detailed_description>HIV infection result impairment function brain spinal cord , lead disturbance ability think clearly strength coordination . This disorder , call AIDS dementia complex , may due direct effect HIV nervous system . It know AZT get brain extent , may reduce growth HIV . It hop AZT stabilize improve symptom AIDS dementia complex . The study do 2 stage . In Stage 1 , patient randomize receive placebo 1 2 dos AZT . Stage 1 last 4 month . In Stage 2 , patient initially treat placebo randomized patient receive AZT . Stage 2 last additional 12 month , time periodic medical neurologic evaluation . Before begin treatment , patient lumbar puncture computerize tomographic ( CT ) scan brain . The lumbar puncture repeat twice end Stage 1 ; CT scan also repeat end Stage 1 . Patients receive AZT either stage 1 Stage 2 see physician every week first 4 week every week thereafter first 4 month receive drug . After 4 month , patient see physician 4 12 week interval .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Aspirin , modest dos . Ibuprofen , modest dos . Maintenance antibiotic therapy posttherapy AIDSdefining opportunistic infection . Concurrent Treatment : Allowed : Blood transfusion cardiovascular status compromise . Exclusion Criteria Active substance abuse . Coexisting Condition : Patients follow condition exclude : Concurrent previous central nervous system infection neoplasms . Active AIDSdefining opportunistic infection . Severe premorbid psychiatric illness . Confounding neurological disease . Concurrent neoplasm . Concurrent Medication : Excluded : Maintenance methadone naltrexone . Acetaminophen . Mood central nervous systemaltering drug . Zidovudine Pneumocystis carinii pneumonia ( PCP ) . Acyclovir . Rifampin derivative . Drugs antiretroviral activity . Experimental agent . The following patient exclude study : Patients require ongoing therapy AIDSdefining opportunistic infection . Patients history Mycobacterium avium intracellulare infection . Patients history Pneumocystis carinii pneumonia infection . Patients daily temperature 38 degree C 1 month . Prior Medication : Excluded : Zidovudine ( AZT ) . Excluded within 14 day study entry : Systemic antiinfectives . Excluded within 30 day study entry : Immunomodulators biologic response modifier . Any investigational agent . Cytotoxic chemotherapy Kaposi 's sarcoma . Prior Treatment : Excluded : Radiation therapy . Patients must demonstrate follow clinical laboratory finding : No currently active AIDSdefining opportunistic infection . One negative blood culture Mycobacterium avium intracellulare within 46 week prior study entry . Constitutionally well without persistent fever . Less 25 Kaposi 's sarcoma lesion less 10 new lesion 30 day prior study entry . Patients may stable indolently progressive mucocutaneous Kaposi 's sarcoma . Characteristic clinical symptom sign AIDS dementia complex . Abnormalities 2 7 neuropsychological motor test Neurological Screening Battery . Estimated premorbid IQ equal great 70 ( + 5 ) , consistent completion sixth grade .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>AIDS Dementia Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>